Drugs / Hemocoagulase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03270735 | Jun 2017 → Jun 2018 | — | Lee's Pharmaceutical Limited | Unknown | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2005-10-17 | Lee's Pharmaceutical Limited | Regulatory New Drug Approval for Hemocoagulase snake venom leespharm.com ↗ |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2006-09-22 | Lee's Pharmaceutical Limited | Marketing Approval for Slounase® (Hemocoagulase) in China leespharm.com ↗ |
| 2005-10-17 | Lee's Pharmaceutical Limited | New Drug Approval for Hemocoagulase snake venom leespharm.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hemocoagulase | “A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection” NCT03270735 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2108960 ↗ |